Quantum mechanical map for protein-ligand binding with application to beta-trypsin/benzamidine complex

Area of Science:

• Computational Chemistry
• Structural Biology
• Biophysics

Background:

• Understanding protein-ligand interactions is crucial for drug discovery.
• Accurate quantum mechanical calculations for large biomolecules are computationally challenging.
• Beta-trypsin and benzamidine serve as a model system for studying enzyme-inhibitor binding.

Purpose of the Study:

• To compute quantum mechanical interaction energies for the beta-trypsin/benzamidine complex.
• To apply the molecular fractionation with conjugate caps (MFCC) approach to a large protein system.
• To gain detailed, amino acid-level insights into protein-ligand binding.

Main Methods:

• Full ab initio Hartree-Fock calculations were performed.
• The molecular fractionation with conjugate caps (MFCC) method was employed to decompose the protein complex.
• Interaction energies were computed for the entire 3238-atom beta-trypsin/benzamidine complex.

Main Results:

• The MFCC approach enabled accurate ab initio energy calculations for the large protein complex.
• An 'interaction spectrum' was generated, detailing quantitative information on protein-ligand binding.
• Specific residue-ligand interactions were identified, providing molecular-level insights.

Conclusions:

• Ab initio calculations using MFCC are feasible for large protein-ligand systems.
• The 'interaction spectrum' offers a powerful tool for understanding binding mechanisms.
• This approach guides the rational design of novel inhibitors for protein targets.